ghk-cu topical use Spray ghk-cu topical safety Essential Serum:

The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida

For a glimpse of what happens when a peptide becomes popular before its been fully developed by a pharma company, consider retatrutide

This serves two purposes

Using a functional wellness approach and blood testing, we help provide a clearer picture of your biomarkers to support informed wellness choices